Exscientia Launches AWS-Powered GenAI Platform for Drug Discovery

Jul 10, 2024, 11:13 AM

Exscientia has launched a state-of-the-art GenAI platform to advance drug discovery, built using AWS technology. The platform integrates generative AI drug design and robotic lab automation to accelerate the delivery of high-quality drugs at faster speeds and lower costs. This development signifies a significant shift in the drug discovery landscape, leveraging massive proprietary datasets and AI to produce intelligence that leads to drug production. Jensen Huang highlighted the scale of data and compute reaching an inflection point in this field.